Navigation Links
RPS Continues Expansion of Global Clinical, Regulatory, Medical, and Operational Leadership
Date:7/20/2011

Research). 

Debra Marshall has over 30 years of healthcare and pharmaceutical industry management experience and most recent served as Assistant Vice President, US Global Site Management for Pfizer (formerly Wyeth), where she was instrumental in building a high performing Site Management Organization and implementing enhanced Site Management strategies.

Lexy Kelley, MD brings strong experience in the design, implementation and medical oversight of clinical development programs for the treatment of Lupus as well as clinical research experience in hematology, infectious diseases, rheumatology and allergy.  Prior to joining RPS, she served as an Associate Medical Director at UCB Pharma.

Marguerite (Peggy) Doran has over 25 years of pharmaceutical industry experience, including 18 years of experience in contract negotiation and management, implementation of sourcing strategies, contract optimization and process improvements as well as vendor relationship management and governance programs.

"Because of our unique business model, RPS has achieved impressive growth rates that far exceed those in the late stage CRO marketplace," said Daniel M. Perlman, Chairman and CEO.  "The new additions to our organization are a key component of our continued focus on growth and innovation in support of the global biopharmaceutical and medical device industries."

About RPS

RPS provides comprehensive global Phase II-IV clinical development solutions to the Pharmaceutical, Biotechnology, Medical Device and Diagnostic industries.  By combining our highly experienced clinical research operations infrastructure with the industry's largest resourcing engines, RPS is uniquely positioned to offer our Customers a broad spectrum of outsourcing solutions. These solutions range from globally Embedded functional and cross-functional programs to enhanced global full-service solutions, and are powered by highly experienced project t
'/>"/>

SOURCE ReSearch Pharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Beardsworth Continues to Strengthen Oncology Operations
2. SeqWright Continues Expansion of Next-Generation Sequencing Capabilities
3. Fourth Annual Probiotics Grant Continues to Fuel Growth In Research
4. IGEN Networks Corp continues to build a world class advisory board, with the appointment of three new members
5. Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation
6. New Test Centre in India: TUV Rheinland Continues Worldwide Investment Programme for Solar Industry
7. Simbionix Continues its Global Expansion
8. O2h Continues to Support Senexis to Support Patent Filing Senexis Limited
9. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
10. NEVO(TM) Sirolimus-Eluting Coronary Stent Continues to Demonstrate Excellent Safety and Efficacy Outcomes in New Twelve-Month Data
11. Dehaier Medical Systems Continues Product Line Expansion. Signs Exclusive Distribution Agreement with HEYER Medical for Respiratory Products in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... ... August 05, 2015 , ... FluidX’s ... from legacy tubes, with 2D barcode labels on the lid, to modern sample ... 2D barcodes in 1 second, using FluidX’s IntelliCode software, which deals easily with ...
(Date:8/5/2015)... ... August 05, 2015 , ... MTI-GlobalStem, ... the launch of an updated corporate identity, including new company name, logo and ... in 2009. The company moved into a new, joint facility in 2014 to ...
(Date:8/4/2015)... Blythewood, South Carolina (PRWEB) , ... August 05, ... ... the first edition of the “Product Handbook – the complete product line.” ... steam system components. , “This new product handbook consolidates our complete standard product ...
(Date:8/4/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a ... for the quarter ending June 30, 2015. Highlights included: ... 2015 , The final cost of the Sarnia ... million above the high end of the estimate communicated ... 10%) , The company announced commercial collaborations in ...
Breaking Biology Technology:RURO Announces FreezerPro® 7 Integration with Top-down 2D barcode scanners by FluidX 2MTI-GlobalStem Announces Updated Company Identity and Website 2MTI-GlobalStem Announces Updated Company Identity and Website 3Spirax Sarco releases Product Handbook 2BioAmber Reports Second Quarter 2015 Financial Results 2BioAmber Reports Second Quarter 2015 Financial Results 3BioAmber Reports Second Quarter 2015 Financial Results 4BioAmber Reports Second Quarter 2015 Financial Results 5BioAmber Reports Second Quarter 2015 Financial Results 6BioAmber Reports Second Quarter 2015 Financial Results 7BioAmber Reports Second Quarter 2015 Financial Results 8BioAmber Reports Second Quarter 2015 Financial Results 9BioAmber Reports Second Quarter 2015 Financial Results 10BioAmber Reports Second Quarter 2015 Financial Results 11BioAmber Reports Second Quarter 2015 Financial Results 12
... Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced its financial results ... , , ... quarter over quarter growth in product sales, driven primarily by our most ... CEO of Angiotech. "In addition, we are encouraged by sales trends for ...
... July 29 Mylan Inc. (Nasdaq: MYL ) today ... in aggregate principal amount of senior notes through a reopening of ... The notes are being offered as additional notes under an existing ... amount of Senior Notes due 2020 on May 19, 2010 ...
... TAI,AN, China , July ... CBPO ) ("China Biologic" or the "Company"), ... the People,s Republic of,China ("PRC"), operating through ... Ltd. ("Taibang") and Guiyang Dalin,Biologic Technologies Co., Ltd. ...
Cached Biology Technology:Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 2Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 3Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 4Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 5Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 6Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 7Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 8Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 9Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 10Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 11Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 12Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 13Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 14Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 15Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 16Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 17Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 18Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 19Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 20Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 21Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 22Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 23Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 24Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 25Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 26Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 27Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 28Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 29Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 30Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 31Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 32Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2010 33Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020 2Mylan Announces Proposed Add-On Private Placement of its Senior Notes Due 2020 3China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference 2
(Date:7/31/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD ... to advance crypto-currencies such as Bitcoin into the consumer ... way to manage all payments.  The ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/27/2015)... 27, 2015   Zynx Health ™, the ... improvement solutions, today announced that its ZynxCarebook ... on Android smartphones and tablets. With this expansion, ... can use ZynxCarebook to securely exchange messages and ... care transitions to other care settings, and improve ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 2Zynx Health Adds Android Device Support to ZynxCarebook Solution 3
... Rochester finds that there is no single advanced area of ... beyond those of any other animal species. Instead, humans rely ... different primitive tasks, in order to make sense of a ... a given sentence, the brain will activate a certain set ...
... , an internationally recognized expert at the University of ... been chosen by the U.S. Department of State to ... Miller is one of only ten persons selected for ... rigorous selection process, are highly accomplished in fields of ...
... in a computerized microworld by scientists at Arizona State ... show how common-pool resources such as fisheries, forests, ... effectively by self-organized user groups under certain conditions. ... Science . "We use different experiments with ...
Cached Biology News:Sign language study shows multiple brain regions wired for language 2Sign language study shows multiple brain regions wired for language 3US Department of State names UCR entomologist a Jefferson Science Fellow 2US Department of State names UCR entomologist a Jefferson Science Fellow 3Communication trumps penalties in new study of social-ecological systems 2Communication trumps penalties in new study of social-ecological systems 3
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
...
... DNA quantitation kit is used to quantitate double-stranded ... of RNA or protein. With this kit, DNA ... be detected with a VersaFluor or other fluorometer. ... 10 ng per ml to 5 micrograms per ...
... colony stimulating factors for assays of mouse ... and fetal liver. Suitable for the ... CFU-GEMM when added to methylcellulose at a ... erythropoietin. Will also support growth of ...
Biology Products: